Selected article for: "especially virus and immune response"

Author: Perlman, Stanley
Title: Research Driven by Curiosity: The Journey from Basic Molecular Biology and Virology to Studies of Human Pathogenic Coronaviruses
  • Document date: 2015_7_14
  • ID: 1tyw4msn_4
    Snippet: CD8 T cells are important for MHV clearance, but they did not appear to be the main factor in immunopathological disease. The second major discovery was that another type of T cell, the CD4 T cell, was the major factor in host tissue damage in MHV-infected mice, and that virus-specific CD4 T cells were responsible for much of the tissue destruction and clinical disease. These results led to questions about how the immune response is normally turn.....
    Document: CD8 T cells are important for MHV clearance, but they did not appear to be the main factor in immunopathological disease. The second major discovery was that another type of T cell, the CD4 T cell, was the major factor in host tissue damage in MHV-infected mice, and that virus-specific CD4 T cells were responsible for much of the tissue destruction and clinical disease. These results led to questions about how the immune response is normally turned off after virus clearance to prevent tissue damage and why this was not completely successful in MHV-infected animals. The third discovery, addressing these questions, was the identification of small numbers of virus-specific regulatory CD4 T cells, which turn off harmful immune responses, especially those caused by virus-specific CD4 T cells. This observation, in turn, raised questions about why these cells were present in only low numbers in the infected host and raised the possibility that these cells represent a therapeutic option in patients with viral encephalitis or other infectious diseases with an immunopathological component.

    Search related documents:
    Co phrase search for related documents
    • clinical disease and host tissue: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical disease and host tissue damage: 1, 2
    • clinical disease and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical disease and immunopathological disease: 1, 2, 3, 4, 5, 6, 7
    • clinical disease and infected host: 1, 2, 3, 4, 5, 6, 7
    • clinical disease and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical disease and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • clinical disease and main factor: 1, 2, 3
    • clinical disease and major discovery: 1
    • clinical disease and major factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • clinical disease and mhv clearance: 1, 2
    • harmful immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • host tissue and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • host tissue and immunopathological disease: 1
    • host tissue and infected host: 1, 2, 3, 4, 5, 6, 7
    • host tissue and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • host tissue and main factor: 1, 2
    • host tissue and major factor: 1, 2
    • host tissue damage and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14